Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
In the ATTAIN-1 trial, adverse events led to treatment discontinuation in up to 10.3 percent of patients on the drug, compared to only 2.7 percent on placebo
Semaglutide is a proven, FDA-approved solution for patients seeking meaningful weight loss outcomes
This medication helps you build lasting habits, manage appetite, and make steady, meaningful progress toward your weight goals
Huber TJ, Tettenborn C, Leifke E, Emrich HM (2005)
As treatment continues, many individuals experience a gradual reduction in symptom severity as physiological adaptation occurs
US$ 22.70
US$ 29.94
US$ 25.75
US$ 24.25
US$ 22.10
US$ 26.40
US$ 27.99
